• Ascendis Pharma average return on equity for 2023 was -4589, a 6218.33% decline from 2022.
• Ascendis Pharma average return on equity for 2022 was -72.63, a 40.89% increase from 2021.
• Ascendis Pharma average return on equity for 2021 was -51.55, a 3.97% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.